United States - English - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

farmacÉutica hispanoamericana, s.a. de c.v. - propionato de fluticasona - propionato de fluticasona....0.5882 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - sertraline hydrochloride - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - sertraline hydrochloride - oral tablet - 50mg

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - paroxetine as hydrochloride - coated tablets - paroxetine as hydrochloride 20 mg - paroxetine - treatment of (in adults):­ major depressive disorder ­ obsessive compulsive disorder (ocd)­ panic disorder with and without agoraphobia­ social anxiety disorders/social phobia­ generalised anxiety disorder­ post-traumatic stress disorder

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - sertraline hydrochloride - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - sertraline hydrochloride - oral tablet - 100mg

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sertraline as hydrochloride - film coated tablets - sertraline as hydrochloride 50 mg - sertraline - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in prevention relapse of the initial episode of depression or recurrence of further depressive episodes.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sun vector sdn bhd - rhizoma curculigo orchioides; radix polygonum lapathisfolium; radix cynomorium songaricum; radix artemisia apiacea; herba epimedium grandiflorum; semen prunus armeniaca -

Israel - English - Ministry of Health

neopharm ltd, israel - tetrabenazine - tablets - tetrabenazine 25 mg - tetrabenazine - tetrabenazine - movement disorders, associated with organic central nervous system conditions, e.g. huntington's chorea, hemiballismus and senile chorea.moderate to severe tardive dyskinesia, which is disabling and/or socially embarrassing. the condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.